Sanofi, 10% Owner at REGENERON PHARMACEUTICALS INC (REGN), sold 262,230 shares at $412.17 ($108.1M) on 2019-03-08, disclosed to the SEC on 2019-03-12.
Open-market sale of $108.1M REGN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $412.17 | 131,115 | $54.0M | 50.0% |
| 2 | $412.17 | 131,115 | $54.0M | 50.0% |
| Total | $412.17 avg | 262,230 | $108.1M | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |